Alkem Laboratories Limited — Updates, 30-12-2025: General Updates
30-12-2025 | 05:11 pm
30-12-2025 | 05:11 pm
Alkem Labs received the final ₹32.5 Cr payment for its trade generics business transfer to Alkem Wellness, a wholly-owned subsidiary. The aggregate sale consideration is now ₹532.5 Cr, completing the slump sale.
No comments yet. Be the first to comment!
